Characterizing the cross-sectional approach to Ovarian cancer: Genetic testing of BRCA - CHARLOTTE

Study identifier:D0816R00013

ClinicalTrials.gov identifier:NCT03229122

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Japan CHARLOTTE: Characterizing the cross-sectional approach to Ovarian cancer: Genetic testing of BRCA

Medical condition

ovarian cancer

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

Female

Actual Enrollment

446

Study type

Observational

Age

20 Years - 130 Years

Date

Study Start Date: 26 Dec 2016
Primary Completion Date: 06 Jul 2018
Study Completion Date: 06 Jul 2018

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: Open Label
Primary Purpose: -

Verification:

Verified 01 Jun 2019 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria